Though, if they did that to show to Fuji that a TO was not going to work and instead they should agree with Celularity to allow CYP to continue as an entity in it's own right producing therapies for both companies, would that not be in shareholder interests in the longer term?
W
- Forums
- ASX - By Stock
- CYP
- IPO's and valuations
CYP
cynata therapeutics limited
Add to My Watchlist
7.69%
!
1.2¢
IPO's and valuations, page-152
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
